Mizuho Securities USA LLC Has $5.15 Million Holdings in CME Group Inc. (NASDAQ:CME)

Mizuho Securities USA LLC lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 15.9% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 23,350 shares of the financial services provider’s stock after selling 4,416 shares during the period. Mizuho Securities USA LLC’s holdings in CME Group were worth $5,152,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. CreativeOne Wealth LLC bought a new stake in shares of CME Group in the 1st quarter worth $315,000. Canada Pension Plan Investment Board grew its position in CME Group by 75.7% in the 1st quarter. Canada Pension Plan Investment Board now owns 547,913 shares of the financial services provider’s stock worth $117,960,000 after purchasing an additional 236,017 shares in the last quarter. Keeley Teton Advisors LLC lifted its position in shares of CME Group by 93.6% during the 1st quarter. Keeley Teton Advisors LLC now owns 2,275 shares of the financial services provider’s stock worth $490,000 after buying an additional 1,100 shares in the last quarter. LRI Investments LLC purchased a new position in shares of CME Group in the 1st quarter worth approximately $100,000. Finally, Epoch Investment Partners Inc. boosted its stake in shares of CME Group by 4.7% in the 1st quarter. Epoch Investment Partners Inc. now owns 99,947 shares of the financial services provider’s stock worth $21,518,000 after buying an additional 4,454 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In related news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now owns 7,275 shares in the company, valued at $1,652,298. This trade represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock valued at $3,441,063 in the last 90 days. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Piper Sandler increased their target price on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday, October 28th. Barclays lifted their price target on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a report on Thursday, October 24th. Citigroup increased their price objective on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Finally, TD Cowen began coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $224.47.

CME Group Stock Down 0.5 %

Shares of NASDAQ CME opened at $226.96 on Friday. The stock has a market capitalization of $81.79 billion, a P/E ratio of 23.87, a PEG ratio of 5.30 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.74. The firm’s 50 day simple moving average is $223.40 and its two-hundred day simple moving average is $210.92. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the business earned $2.25 earnings per share. The company’s quarterly revenue was up 18.4% on a year-over-year basis. As a group, analysts expect that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.03%. CME Group’s payout ratio is presently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.